First patient recieves stem-cell retina in Japan

A Japanese woman in her 70s is the world’s first recipient of cells derived from induced pluripotent stem cells, a technology that has created great expectations since it could offer the same advantages as embryo-derived cells but without some of the controversial aspects and safety concerns.

In a two-hour procedure starting at 2:20 p.m. local time today, a team of three eye specialists lead by Yasuo Kurimoto of the Kobe City Medical Center General Hospital, transplanted a 1.3 by 3.0 millimetre sheet of retinal pigment epithelium cells into an eye of the Hyogo prefecture resident, who suffers from age-related macular degeneration.

The procedure took place at the Institute of Biomedical Research and Innovation Hospital, next to the RIKEN Center for Developmental Biology (CDB) where ophthalmologist Masayo Takahashi had developed and tested the epithelium sheets. She derived them from the patient’s skin cells, after producing induced pluripotent stem (iPS) cells and then getting them to differentiate into retinal cells.

Read the full, original story: Japanese woman is first recipient of next-generation stem cells

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2026-07-11 094410
Growing animal muscle and fat cells inside rice grains and calling it beef: One of numerous genetically engineered products shaking up our ecosystem
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
file-f-d-d-
Facts & Fallacies Podcast: Europe's AC debacle underscores fatal flaw in green activism
Screenshot-2026-07-16-at-11.32.12-AM
Viewpoint: Trump appoints climate change hoax promoter to head influential government policy project
Screenshot 2026-07-16 at 8.49
Pete Hegseth’s bizarre Viagra commercial as Trump administration endorses ‘hormone replacement therapy’
Screenshot-2026-07-16-at-6.02.54-PM
Wellness grifters overwhelm information channels in the developing world, and the problem is escalating
Screenshot-2026-07-16-at-12.08.38-PM
Viewpoint: With trust in doctors and mainstream medicine collapsing, medical professionals need a new communications strategy
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jul-9-2026-02_39_22-PM
Viewpoint: Polyphenols or NAD+ supplements to combat aging: No, Gwenyth Paltrow and followers, don’t waste your money.
ChatGPT-Image-Jul-1-2026-03_33_49-PM
‘Alternative’ cancer treatments that could kill you
Screenshot 2025-09-17 at 12.41
Misinformation alert: No, glyphosate use in Canadian forests is not spurring more wildfires
afb-a-b
As the EU loosens restrictions on agricultural gene editing, it remains years behind the rest of the world on equally-safe GMO foods
Screenshot-2026-07-08-at-9.36.03-AM
Viewpoint: Long-contained diseases are on the rise in the U.S. Are Trump cuts to blame?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.